Agios Pharmaceuticals Inc
Veridion Score
Composite trend over time
Why is AGIO moving today?
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for AGIO.
AGIO insider activity
Agios Pharmaceuticals Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$5.7M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | 2026-04-02 | Burns James William | Insider | sell | $34.71 | 3,280 | 49,306 | $114K | SEC Form 4 |
| 2026-04-06 | 2026-04-02 | Gheuens Sarah | Insider | sell | $34.71 | 2,940 | 80,277 | $102K | SEC Form 4 |
| 2026-04-06 | 2026-04-02 | Jones Cecilia | Insider | sell | $34.71 | 3,141 | 54,998 | $109K | SEC Form 4 |
| 2026-04-06 | 2026-04-02 | Milanova Tsveta | Insider | sell | $34.71 | 3,262 | 46,829 | $113K | SEC Form 4 |
| 2026-04-06 | 2026-04-02 | Viswanadhan Krishnan | Insider | sell | $34.71 | 2,959 | 10,282 | $103K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 59 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moAGIO contract awards, year to date.
Public federal awards linked to this ticker.
AGIO lobbying filings, year to date.
Registered lobbying filings matched to Agios Pharmaceuticals Inc.
AGIOS PHARMACEUTICALS
AGIOS PHARMACEUTICALS
JEFFREY J. KIMBELL & ASSOCIATES, INC.